Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.35924390 |
2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.51182791 |
3 | modulation by symbiont of host defense response (GO:0052031) | 5.51182791 |
4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.51182791 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.51182791 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.51182791 |
7 | modulation by symbiont of host immune response (GO:0052553) | 5.51182791 |
8 | neutrophil activation involved in immune response (GO:0002283) | 5.13761161 |
9 | glycosphingolipid catabolic process (GO:0046479) | 5.08084753 |
10 | oligosaccharide catabolic process (GO:0009313) | 4.72323963 |
11 | amino sugar catabolic process (GO:0046348) | 4.60409435 |
12 | glycolipid catabolic process (GO:0019377) | 4.56417653 |
13 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.53734942 |
14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.48933651 |
15 | positive regulation of interferon-alpha production (GO:0032727) | 4.46382393 |
16 | immunoglobulin mediated immune response (GO:0016064) | 4.41652280 |
17 | response to peptidoglycan (GO:0032494) | 4.35285268 |
18 | regulation of interferon-alpha production (GO:0032647) | 4.25337786 |
19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.24803502 |
20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.19986558 |
21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.19986558 |
22 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.15472439 |
23 | ceramide catabolic process (GO:0046514) | 4.09037216 |
24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.07576089 |
25 | respiratory burst (GO:0045730) | 4.05839499 |
26 | macrophage activation involved in immune response (GO:0002281) | 4.00352613 |
27 | response to thyroid hormone (GO:0097066) | 3.83166041 |
28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.82050598 |
29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.69628122 |
30 | response to host immune response (GO:0052572) | 3.65436572 |
31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.65436572 |
32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.64157192 |
33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.62456725 |
34 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.56294633 |
35 | positive regulation of mast cell degranulation (GO:0043306) | 3.52839291 |
36 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.52839291 |
37 | myeloid cell activation involved in immune response (GO:0002275) | 3.52273612 |
38 | positive regulation of leukocyte degranulation (GO:0043302) | 3.51149071 |
39 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.50807195 |
40 | granulocyte activation (GO:0036230) | 3.46374682 |
41 | type I interferon signaling pathway (GO:0060337) | 3.46340730 |
42 | cellular response to type I interferon (GO:0071357) | 3.46340730 |
43 | response to type I interferon (GO:0034340) | 3.45247972 |
44 | B cell mediated immunity (GO:0019724) | 3.44393742 |
45 | N-acetylneuraminate metabolic process (GO:0006054) | 3.43151082 |
46 | leukocyte aggregation (GO:0070486) | 3.38534927 |
47 | neutrophil activation (GO:0042119) | 3.38508741 |
48 | response to interferon-alpha (GO:0035455) | 3.34114114 |
49 | response to host (GO:0075136) | 3.30685040 |
50 | response to host defenses (GO:0052200) | 3.30685040 |
51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30685040 |
52 | negative regulation of cell killing (GO:0031342) | 3.30601447 |
53 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.30601447 |
54 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28976665 |
55 | regulation of leukocyte degranulation (GO:0043300) | 3.28570436 |
56 | positive regulation of interferon-beta production (GO:0032728) | 3.27925210 |
57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.27755404 |
58 | membrane lipid catabolic process (GO:0046466) | 3.27548340 |
59 | NIK/NF-kappaB signaling (GO:0038061) | 3.27312613 |
60 | response to muramyl dipeptide (GO:0032495) | 3.25583329 |
61 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.25259335 |
62 | response to interferon-beta (GO:0035456) | 3.22924070 |
63 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.22881186 |
64 | sphingolipid catabolic process (GO:0030149) | 3.22431301 |
65 | regulation of macrophage chemotaxis (GO:0010758) | 3.21415280 |
66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.20963292 |
67 | T-helper 1 type immune response (GO:0042088) | 3.20803642 |
68 | regulation of cholesterol storage (GO:0010885) | 3.20643327 |
69 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.20472883 |
70 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.17166058 |
71 | defense response to protozoan (GO:0042832) | 3.16272227 |
72 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.16143363 |
73 | regulation of superoxide anion generation (GO:0032928) | 3.15536530 |
74 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.15117886 |
75 | natural killer cell mediated immunity (GO:0002228) | 3.15117886 |
76 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.15054993 |
77 | regulation of antigen processing and presentation (GO:0002577) | 3.12867496 |
78 | cellular response to zinc ion (GO:0071294) | 3.11873572 |
79 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.08776326 |
80 | detection of other organism (GO:0098543) | 3.07853287 |
81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.07506018 |
82 | positive regulation of mast cell activation (GO:0033005) | 3.06455442 |
83 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.04663216 |
84 | macrophage differentiation (GO:0030225) | 3.04263192 |
85 | myeloid dendritic cell differentiation (GO:0043011) | 3.01784580 |
86 | cellular response to interferon-beta (GO:0035458) | 3.01529548 |
87 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.01097238 |
88 | T cell migration (GO:0072678) | 3.00138578 |
89 | myeloid dendritic cell activation (GO:0001773) | 2.98626342 |
90 | regulation of gamma-delta T cell activation (GO:0046643) | 2.98319581 |
91 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.97308623 |
92 | regulation of podosome assembly (GO:0071801) | 2.94333306 |
93 | pinocytosis (GO:0006907) | 2.94221097 |
94 | regulation of B cell differentiation (GO:0045577) | 2.93507492 |
95 | response to protozoan (GO:0001562) | 2.93445697 |
96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.92870605 |
97 | detection of external biotic stimulus (GO:0098581) | 2.90405555 |
98 | phagosome maturation (GO:0090382) | 2.88923487 |
99 | eosinophil chemotaxis (GO:0048245) | 2.87780156 |
100 | detection of bacterium (GO:0016045) | 2.87252092 |
101 | leukocyte cell-cell adhesion (GO:0007159) | 2.87003338 |
102 | positive regulation of B cell differentiation (GO:0045579) | 2.86647500 |
103 | protein localization to endosome (GO:0036010) | 2.86403123 |
104 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.85199487 |
105 | regulation of mast cell activation (GO:0033003) | 2.85183752 |
106 | regulation of monocyte chemotaxis (GO:0090025) | 2.84319342 |
107 | regulation of mononuclear cell migration (GO:0071675) | 2.83860987 |
108 | B cell receptor signaling pathway (GO:0050853) | 2.83219440 |
109 | actin nucleation (GO:0045010) | 2.82048319 |
110 | superoxide anion generation (GO:0042554) | 2.81635512 |
111 | regulation of mast cell degranulation (GO:0043304) | 2.79567946 |
112 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.78881963 |
113 | microglial cell activation (GO:0001774) | 2.78657842 |
114 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.77996698 |
115 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.77655266 |
116 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.76794828 |
117 | apoptotic cell clearance (GO:0043277) | 2.76153087 |
118 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.75050629 |
119 | sequestering of actin monomers (GO:0042989) | 2.74849140 |
120 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.74712670 |
121 | dendritic cell differentiation (GO:0097028) | 2.74313890 |
122 | positive regulation of cholesterol efflux (GO:0010875) | 2.74145988 |
123 | macrophage activation (GO:0042116) | 2.74049744 |
124 | mast cell activation (GO:0045576) | 2.73778205 |
125 | myeloid leukocyte activation (GO:0002274) | 2.73611572 |
126 | cellular extravasation (GO:0045123) | 2.73431748 |
127 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.73063890 |
128 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72777672 |
129 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.72076525 |
130 | cellular response to interferon-alpha (GO:0035457) | 2.71059499 |
131 | monocyte chemotaxis (GO:0002548) | 2.69285772 |
132 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.68995648 |
133 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.68600537 |
134 | lymphocyte chemotaxis (GO:0048247) | 2.67415250 |
135 | regulation of hypersensitivity (GO:0002883) | 2.66854141 |
136 | negative regulation of interleukin-12 production (GO:0032695) | 2.66751974 |
137 | regulation of chemokine biosynthetic process (GO:0045073) | 2.66619083 |
138 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.66039712 |
139 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.66030698 |
140 | peptide catabolic process (GO:0043171) | 2.65736416 |
141 | leukocyte degranulation (GO:0043299) | 2.65314454 |
142 | positive regulation of macrophage differentiation (GO:0045651) | 2.63751160 |
143 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.63450995 |
144 | negative regulation of viral genome replication (GO:0045071) | 2.63376960 |
145 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.63179110 |
146 | mature B cell differentiation involved in immune response (GO:0002313) | 2.62350015 |
147 | detection of molecule of bacterial origin (GO:0032490) | 2.62151651 |
148 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.62091583 |
149 | cellular response to interferon-gamma (GO:0071346) | 2.60431118 |
150 | eosinophil migration (GO:0072677) | 2.58448425 |
151 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.56814708 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.88349772 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.81400628 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.14444751 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.69164157 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.56913177 |
6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41164341 |
7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.33612455 |
8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26621998 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25920055 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22334958 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.89782296 |
12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.89429861 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80849378 |
14 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.66713843 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.64783530 |
16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.59397358 |
17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.46165218 |
18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.44426705 |
19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40684091 |
20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.37005716 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31955981 |
22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.31165350 |
23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24678627 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18323206 |
25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.10684169 |
26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09210229 |
27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95116279 |
28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93707865 |
29 | * MYB_26560356_Chip-Seq_TH2_Human | 1.90604186 |
30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90559766 |
31 | MAF_26560356_Chip-Seq_TH1_Human | 1.90541096 |
32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85182730 |
33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82710721 |
34 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.72643632 |
35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71935365 |
36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66057660 |
37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63482931 |
38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.60318701 |
39 | MYB_26560356_Chip-Seq_TH1_Human | 1.59453296 |
40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55847883 |
41 | MYC_22102868_ChIP-Seq_BL_Human | 1.55760769 |
42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54664759 |
43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.51193001 |
44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50497201 |
45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50343844 |
46 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48053788 |
47 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46556580 |
48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46467514 |
49 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.46388596 |
50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40110209 |
51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39514858 |
52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36303832 |
53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34822947 |
54 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.34201349 |
55 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32736983 |
56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32320571 |
57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31857147 |
58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31409182 |
59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28692718 |
60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28041255 |
61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27578965 |
62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26980178 |
63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22500725 |
64 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21637771 |
65 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.21369275 |
66 | MAF_26560356_Chip-Seq_TH2_Human | 1.19448597 |
67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18201122 |
68 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.18084954 |
69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16140877 |
70 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15096821 |
71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13677914 |
72 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13566919 |
73 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12589225 |
74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09994525 |
75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09756649 |
76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09521650 |
77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09014700 |
78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07960310 |
79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07828640 |
80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07505824 |
81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07483197 |
82 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06942896 |
83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05899005 |
84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05630072 |
85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05622694 |
86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05347721 |
87 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05267282 |
88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05215710 |
89 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03266671 |
90 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01904655 |
91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96913978 |
92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95958624 |
93 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95279683 |
94 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94239905 |
95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94169494 |
96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94028404 |
97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93801199 |
98 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.93222574 |
99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93147648 |
100 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92308334 |
101 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92108550 |
102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91295202 |
103 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88998056 |
104 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88998056 |
105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88613113 |
106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88325987 |
107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88077633 |
108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87653161 |
109 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.86851718 |
110 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84910350 |
111 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84665179 |
112 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.83977587 |
113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81442798 |
114 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78469769 |
115 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.77732593 |
116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77573884 |
117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76366045 |
118 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75050123 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.15355714 |
2 | MP0003436_decreased_susceptibility_to | 3.75293354 |
3 | MP0009785_altered_susceptibility_to | 3.43144731 |
4 | MP0003303_peritoneal_inflammation | 3.21443527 |
5 | MP0005000_abnormal_immune_tolerance | 3.05234441 |
6 | MP0006082_CNS_inflammation | 2.99945040 |
7 | MP0002148_abnormal_hypersensitivity_rea | 2.98853509 |
8 | MP0005058_abnormal_lysosome_morphology | 2.94383368 |
9 | * MP0002419_abnormal_innate_immunity | 2.90732869 |
10 | MP0000685_abnormal_immune_system | 2.89036083 |
11 | * MP0005025_abnormal_response_to | 2.77298759 |
12 | MP0001790_abnormal_immune_system | 2.72079717 |
13 | MP0005387_immune_system_phenotype | 2.72079717 |
14 | MP0005671_abnormal_response_to | 2.65092471 |
15 | * MP0002452_abnormal_antigen_presenting | 2.63272111 |
16 | MP0001800_abnormal_humoral_immune | 2.54835094 |
17 | MP0003724_increased_susceptibility_to | 2.50234156 |
18 | MP0002723_abnormal_immune_serum | 2.45681065 |
19 | * MP0001819_abnormal_immune_cell | 2.29920083 |
20 | * MP0002420_abnormal_adaptive_immunity | 2.28929320 |
21 | MP0004510_myositis | 2.28164781 |
22 | MP0003806_abnormal_nucleotide_metabolis | 2.18182766 |
23 | MP0005464_abnormal_platelet_physiology | 2.14446443 |
24 | MP0004947_skin_inflammation | 2.13211403 |
25 | MP0003172_abnormal_lysosome_physiology | 2.11956216 |
26 | MP0002405_respiratory_system_inflammati | 2.09399125 |
27 | MP0001533_abnormal_skeleton_physiology | 2.07800916 |
28 | MP0001853_heart_inflammation | 1.94565928 |
29 | MP0002139_abnormal_hepatobiliary_system | 1.92310842 |
30 | MP0001845_abnormal_inflammatory_respons | 1.83198142 |
31 | MP0010155_abnormal_intestine_physiology | 1.77182195 |
32 | MP0009333_abnormal_splenocyte_physiolog | 1.76299244 |
33 | MP0000343_altered_response_to | 1.75553040 |
34 | MP0002398_abnormal_bone_marrow | 1.74194027 |
35 | MP0000716_abnormal_immune_system | 1.73651694 |
36 | MP0003448_altered_tumor_morphology | 1.73427383 |
37 | MP0005451_abnormal_body_composition | 1.66339312 |
38 | MP0002933_joint_inflammation | 1.64777547 |
39 | MP0003300_gastrointestinal_ulcer | 1.57251115 |
40 | MP0000689_abnormal_spleen_morphology | 1.55947355 |
41 | MP0002006_tumorigenesis | 1.55377015 |
42 | MP0000858_altered_metastatic_potential | 1.55212877 |
43 | MP0002166_altered_tumor_susceptibility | 1.53735732 |
44 | MP0008469_abnormal_protein_level | 1.49532435 |
45 | MP0008438_abnormal_cutaneous_collagen | 1.47146050 |
46 | MP0002429_abnormal_blood_cell | 1.46159038 |
47 | MP0002722_abnormal_immune_system | 1.45710469 |
48 | MP0002998_abnormal_bone_remodeling | 1.42617677 |
49 | MP0005310_abnormal_salivary_gland | 1.42149756 |
50 | MP0001545_abnormal_hematopoietic_system | 1.41446054 |
51 | MP0005397_hematopoietic_system_phenotyp | 1.41446054 |
52 | MP0008260_abnormal_autophagy | 1.40806281 |
53 | MP0003329_amyloid_beta_deposits | 1.40027807 |
54 | MP0003191_abnormal_cellular_cholesterol | 1.39542008 |
55 | MP0003763_abnormal_thymus_physiology | 1.38729585 |
56 | MP0003566_abnormal_cell_adhesion | 1.38468286 |
57 | MP0009278_abnormal_bone_marrow | 1.36959745 |
58 | MP0009764_decreased_sensitivity_to | 1.33754797 |
59 | MP0009840_abnormal_foam_cell | 1.30761761 |
60 | MP0001851_eye_inflammation | 1.28853772 |
61 | MP0001873_stomach_inflammation | 1.24086253 |
62 | MP0010307_abnormal_tumor_latency | 1.22480858 |
63 | MP0000465_gastrointestinal_hemorrhage | 1.21947530 |
64 | MP0003075_altered_response_to | 1.20923577 |
65 | MP0005257_abnormal_intraocular_pressure | 1.20156982 |
66 | MP0005174_abnormal_tail_pigmentation | 1.15229059 |
67 | MP0004808_abnormal_hematopoietic_stem | 1.12367635 |
68 | MP0003705_abnormal_hypodermis_morpholog | 1.11047884 |
69 | MP0000604_amyloidosis | 1.10187737 |
70 | MP0005390_skeleton_phenotype | 1.09977244 |
71 | MP0005165_increased_susceptibility_to | 1.09805725 |
72 | MP0005023_abnormal_wound_healing | 1.09019746 |
73 | MP0005166_decreased_susceptibility_to | 1.08693169 |
74 | MP0000490_abnormal_crypts_of | 1.07298703 |
75 | MP0001958_emphysema | 1.07067479 |
76 | MP0002396_abnormal_hematopoietic_system | 1.02866213 |
77 | MP0000920_abnormal_myelination | 1.00093812 |
78 | MP0010352_gastrointestinal_tract_polyps | 0.96154709 |
79 | MP0005365_abnormal_bile_salt | 0.90742999 |
80 | MP0003828_pulmonary_edema | 0.90487545 |
81 | MP0003453_abnormal_keratinocyte_physiol | 0.89830522 |
82 | MP0003186_abnormal_redox_activity | 0.88759899 |
83 | MP0000703_abnormal_thymus_morphology | 0.87954698 |
84 | MP0003866_abnormal_defecation | 0.87040023 |
85 | MP0004883_abnormal_blood_vessel | 0.86817366 |
86 | MP0003795_abnormal_bone_structure | 0.86083864 |
87 | MP0001542_abnormal_bone_strength | 0.85667637 |
88 | MP0003279_aneurysm | 0.85037415 |
89 | MP0009763_increased_sensitivity_to | 0.82606795 |
90 | MP0005076_abnormal_cell_differentiation | 0.81526659 |
91 | MP0002254_reproductive_system_inflammat | 0.81416188 |
92 | MP0008004_abnormal_stomach_pH | 0.80411929 |
93 | MP0003656_abnormal_erythrocyte_physiolo | 0.78709635 |
94 | MP0005164_abnormal_response_to | 0.77212802 |
95 | MP0005167_abnormal_blood-brain_barrier | 0.76833251 |
96 | MP0003091_abnormal_cell_migration | 0.74706594 |
97 | MP0001849_ear_inflammation | 0.74054844 |
98 | MP0004782_abnormal_surfactant_physiolog | 0.73813739 |
99 | MP0000249_abnormal_blood_vessel | 0.73114232 |
100 | MP0002136_abnormal_kidney_physiology | 0.70401127 |
101 | MP0000371_diluted_coat_color | 0.68851624 |
102 | MP0002090_abnormal_vision | 0.68786080 |
103 | MP0006054_spinal_hemorrhage | 0.68365960 |
104 | MP0000015_abnormal_ear_pigmentation | 0.67578087 |
105 | MP0002019_abnormal_tumor_incidence | 0.67146866 |
106 | MP0005275_abnormal_skin_tensile | 0.65480580 |
107 | MP0001663_abnormal_digestive_system | 0.65372812 |
108 | MP0009765_abnormal_xenobiotic_induced | 0.64500166 |
109 | MP0005319_abnormal_enzyme/_coenzyme | 0.63621244 |
110 | MP0003634_abnormal_glial_cell | 0.62929051 |
111 | MP0000569_abnormal_digit_pigmentation | 0.62801971 |
112 | MP0003690_abnormal_glial_cell | 0.62323989 |
113 | MP0002877_abnormal_melanocyte_morpholog | 0.59754218 |
114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59347072 |
115 | MP0008874_decreased_physiological_sensi | 0.58885155 |
116 | MP0000609_abnormal_liver_physiology | 0.57321344 |
117 | MP0003183_abnormal_peptide_metabolism | 0.57187289 |
118 | MP0002332_abnormal_exercise_endurance | 0.57127350 |
119 | MP0001216_abnormal_epidermal_layer | 0.57118963 |
120 | MP0002837_dystrophic_cardiac_calcinosis | 0.54334562 |
121 | MP0000767_abnormal_smooth_muscle | 0.52434852 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.64225444 |
2 | Eczematoid dermatitis (HP:0000976) | 6.21139722 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.61477986 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.02601117 |
5 | Vacuolated lymphocytes (HP:0001922) | 4.97084993 |
6 | Abnormality of macrophages (HP:0004311) | 4.78377046 |
7 | Increased cerebral lipofuscin (HP:0011813) | 4.76319146 |
8 | Myositis (HP:0100614) | 4.33189077 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.30867745 |
10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.12102213 |
11 | Mediastinal lymphadenopathy (HP:0100721) | 3.91026194 |
12 | Recurrent skin infections (HP:0001581) | 3.80686454 |
13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.61957008 |
14 | Obstructive lung disease (HP:0006536) | 3.61957008 |
15 | Orchitis (HP:0100796) | 3.60225038 |
16 | Stomatitis (HP:0010280) | 3.59578272 |
17 | Gingivitis (HP:0000230) | 3.57785081 |
18 | Recurrent fungal infections (HP:0002841) | 3.54433519 |
19 | Mutism (HP:0002300) | 3.47798235 |
20 | Neurofibrillary tangles (HP:0002185) | 3.47036350 |
21 | Dysostosis multiplex (HP:0000943) | 3.44566530 |
22 | Systemic lupus erythematosus (HP:0002725) | 3.42252765 |
23 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.28059494 |
24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.28059494 |
25 | Abnormality of glycolipid metabolism (HP:0010969) | 3.28059494 |
26 | Interstitial pulmonary disease (HP:0006530) | 3.27348612 |
27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.24596567 |
28 | Pustule (HP:0200039) | 3.22750971 |
29 | Disinhibition (HP:0000734) | 3.20379305 |
30 | Cellulitis (HP:0100658) | 3.18876916 |
31 | Axonal loss (HP:0003447) | 3.17024421 |
32 | Autoimmune thrombocytopenia (HP:0001973) | 3.11399187 |
33 | Retrobulbar optic neuritis (HP:0100654) | 3.05377568 |
34 | Optic neuritis (HP:0100653) | 3.05377568 |
35 | IgM deficiency (HP:0002850) | 2.98875223 |
36 | Vasculitis (HP:0002633) | 2.96105408 |
37 | Petechiae (HP:0000967) | 2.95602306 |
38 | Nuclear cataract (HP:0100018) | 2.93504453 |
39 | Chronic otitis media (HP:0000389) | 2.89483452 |
40 | Upper motor neuron abnormality (HP:0002127) | 2.88359656 |
41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.88019180 |
42 | Mucopolysacchariduria (HP:0008155) | 2.88019180 |
43 | Basal ganglia calcification (HP:0002135) | 2.82087302 |
44 | Amyloidosis (HP:0011034) | 2.80844420 |
45 | Recurrent viral infections (HP:0004429) | 2.77584541 |
46 | Loss of speech (HP:0002371) | 2.77158579 |
47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.75962434 |
48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.75962434 |
49 | Apathy (HP:0000741) | 2.69003674 |
50 | Increased serum ferritin (HP:0003281) | 2.67855978 |
51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.66378975 |
52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.66378975 |
53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.66378975 |
54 | Progressive neurologic deterioration (HP:0002344) | 2.64560132 |
55 | Glomerulonephritis (HP:0000099) | 2.60957352 |
56 | Recurrent bronchitis (HP:0002837) | 2.60598189 |
57 | Vertebral compression fractures (HP:0002953) | 2.60566281 |
58 | Urticaria (HP:0001025) | 2.59873469 |
59 | Periodontitis (HP:0000704) | 2.58913825 |
60 | Meningitis (HP:0001287) | 2.54810593 |
61 | Neuronal loss in central nervous system (HP:0002529) | 2.53787740 |
62 | Agnosia (HP:0010524) | 2.52028488 |
63 | Recurrent pneumonia (HP:0006532) | 2.49673227 |
64 | Cerebral inclusion bodies (HP:0100314) | 2.47729759 |
65 | Osteomyelitis (HP:0002754) | 2.47509258 |
66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.40847101 |
67 | Hematochezia (HP:0002573) | 2.39350635 |
68 | Osteolytic defects of the hand bones (HP:0009699) | 2.38904711 |
69 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.38904711 |
70 | Prolonged neonatal jaundice (HP:0006579) | 2.37108370 |
71 | Thrombocytosis (HP:0001894) | 2.35728503 |
72 | Nasal polyposis (HP:0100582) | 2.32539203 |
73 | Hepatosplenomegaly (HP:0001433) | 2.32214111 |
74 | Pulmonary infiltrates (HP:0002113) | 2.31435114 |
75 | Abnormality of the nasal mucosa (HP:0000433) | 2.31240350 |
76 | Myocardial infarction (HP:0001658) | 2.30698314 |
77 | Metaphyseal irregularity (HP:0003025) | 2.28707810 |
78 | Retinal atrophy (HP:0001105) | 2.28626672 |
79 | Recurrent lower respiratory tract infections (HP:0002783) | 2.26123074 |
80 | Arterial thrombosis (HP:0004420) | 2.25731131 |
81 | Leukocytosis (HP:0001974) | 2.24480737 |
82 | Inflammation of the large intestine (HP:0002037) | 2.23157583 |
83 | Gastrointestinal stroma tumor (HP:0100723) | 2.23041498 |
84 | Personality changes (HP:0000751) | 2.22074118 |
85 | Increased IgM level (HP:0003496) | 2.21740810 |
86 | Hypergammaglobulinemia (HP:0010702) | 2.20113749 |
87 | Thick nail (HP:0001805) | 2.19503356 |
88 | Prostate neoplasm (HP:0100787) | 2.17198356 |
89 | Emphysema (HP:0002097) | 2.17057658 |
90 | Abnormality of T cell physiology (HP:0011840) | 2.14374115 |
91 | Gastrointestinal inflammation (HP:0004386) | 2.10386521 |
92 | Skin ulcer (HP:0200042) | 2.09565927 |
93 | Inappropriate behavior (HP:0000719) | 2.09151291 |
94 | Dementia (HP:0000726) | 2.08261039 |
95 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.07784951 |
96 | Spontaneous hematomas (HP:0007420) | 2.07137442 |
97 | Abnormality of iron homeostasis (HP:0011031) | 2.06967103 |
98 | Lymphopenia (HP:0001888) | 2.06800613 |
99 | Hemoptysis (HP:0002105) | 2.04983620 |
100 | Abnormality of T cells (HP:0002843) | 2.04397009 |
101 | Poor head control (HP:0002421) | 2.03743280 |
102 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02178063 |
103 | Gingival bleeding (HP:0000225) | 2.01496453 |
104 | Abnormality of the periventricular white matter (HP:0002518) | 2.00655618 |
105 | Thoracic kyphosis (HP:0002942) | 2.00323909 |
106 | Bone pain (HP:0002653) | 1.98647658 |
107 | Premature loss of primary teeth (HP:0006323) | 1.95977312 |
108 | Abnormality of the lumbar spine (HP:0100712) | 1.95386099 |
109 | Increased IgE level (HP:0003212) | 1.93992490 |
110 | Diminished motivation (HP:0000745) | 1.93617656 |
111 | Colitis (HP:0002583) | 1.93406660 |
112 | Cardiomegaly (HP:0001640) | 1.93186567 |
113 | Asymmetric septal hypertrophy (HP:0001670) | 1.92718176 |
114 | Epistaxis (HP:0000421) | 1.91053953 |
115 | Complement deficiency (HP:0004431) | 1.89308678 |
116 | Beaking of vertebral bodies (HP:0004568) | 1.88690022 |
117 | Arthralgia (HP:0002829) | 1.88469371 |
118 | Albinism (HP:0001022) | 1.88468622 |
119 | Purpura (HP:0000979) | 1.87658065 |
120 | Supranuclear gaze palsy (HP:0000605) | 1.85975360 |
121 | Xanthomatosis (HP:0000991) | 1.85744858 |
122 | Peripheral demyelination (HP:0011096) | 1.85125718 |
123 | Prolonged bleeding time (HP:0003010) | 1.84932436 |
124 | J-shaped sella turcica (HP:0002680) | 1.84913615 |
125 | IgA deficiency (HP:0002720) | 1.84842458 |
126 | Malnutrition (HP:0004395) | 1.84639035 |
127 | T lymphocytopenia (HP:0005403) | 1.84249664 |
128 | Sepsis (HP:0100806) | 1.83504571 |
129 | Pathologic fracture (HP:0002756) | 1.81786060 |
130 | Restrictive lung disease (HP:0002091) | 1.81221963 |
131 | Polyneuropathy (HP:0001271) | 1.81133723 |
132 | Neoplasm of head and neck (HP:0012288) | 1.78858750 |
133 | Esophageal neoplasm (HP:0100751) | 1.78858750 |
134 | Abnormality of complement system (HP:0005339) | 1.77287633 |
135 | Multiple enchondromatosis (HP:0005701) | 1.74642131 |
136 | Global brain atrophy (HP:0002283) | 1.69944651 |
137 | Increased CSF protein (HP:0002922) | 1.66959799 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.91405299 |
2 | TBK1 | 3.25726587 |
3 | BLK | 3.24088287 |
4 | NME2 | 3.03768518 |
5 | KIT | 2.87406455 |
6 | ERN1 | 2.82967775 |
7 | MAP3K14 | 2.77656240 |
8 | GRK7 | 2.59516446 |
9 | TYK2 | 2.59274506 |
10 | RIPK4 | 2.48243304 |
11 | IRAK4 | 2.41747599 |
12 | ZAP70 | 2.35229692 |
13 | PBK | 2.25569636 |
14 | IKBKE | 2.21697221 |
15 | JAK3 | 2.20233377 |
16 | TXK | 2.13082968 |
17 | IRAK3 | 2.06799236 |
18 | PIM2 | 2.02946511 |
19 | IKBKB | 1.96610937 |
20 | PRPF4B | 1.71116000 |
21 | TESK2 | 1.62938196 |
22 | TRIB3 | 1.62811372 |
23 | DDR2 | 1.62379300 |
24 | MAP2K3 | 1.61998720 |
25 | BTK | 1.60975891 |
26 | SYK | 1.58921050 |
27 | TGFBR2 | 1.56792657 |
28 | RPS6KA4 | 1.53259473 |
29 | TESK1 | 1.48845360 |
30 | JAK1 | 1.48366776 |
31 | STK10 | 1.48245493 |
32 | LRRK2 | 1.45324941 |
33 | KDR | 1.44694410 |
34 | HCK | 1.44523835 |
35 | CSF1R | 1.44035603 |
36 | CSK | 1.39211879 |
37 | NEK9 | 1.36621532 |
38 | MAP3K11 | 1.30747945 |
39 | SCYL2 | 1.27709542 |
40 | PKN2 | 1.27218801 |
41 | LCK | 1.26922861 |
42 | TEC | 1.26791297 |
43 | TTN | 1.19534272 |
44 | TAOK1 | 1.19285871 |
45 | LYN | 1.18790848 |
46 | MAP3K3 | 1.14091557 |
47 | TRPM7 | 1.13250420 |
48 | MAP3K12 | 1.10031037 |
49 | MAP3K13 | 1.08526501 |
50 | PDK2 | 1.03221964 |
51 | CHUK | 1.00470664 |
52 | CDC42BPA | 0.98055156 |
53 | MATK | 0.95503360 |
54 | ABL2 | 0.94634507 |
55 | FES | 0.91879507 |
56 | MST4 | 0.91625534 |
57 | PAK4 | 0.91440727 |
58 | PIM1 | 0.90522021 |
59 | EPHB1 | 0.90399277 |
60 | BMPR2 | 0.86491529 |
61 | FGFR4 | 0.79149660 |
62 | ITK | 0.77727709 |
63 | SIK3 | 0.76919872 |
64 | JAK2 | 0.76168696 |
65 | BCKDK | 0.76091063 |
66 | FGR | 0.75278135 |
67 | BMX | 0.75256084 |
68 | MOS | 0.72752182 |
69 | EIF2AK1 | 0.69258061 |
70 | TAOK3 | 0.63927480 |
71 | MARK3 | 0.63657961 |
72 | PRKCD | 0.63328063 |
73 | TGFBR1 | 0.62115423 |
74 | RPS6KA2 | 0.61963749 |
75 | ABL1 | 0.61232089 |
76 | PDPK1 | 0.60924021 |
77 | ADRBK2 | 0.60404832 |
78 | GRK6 | 0.59935199 |
79 | FGFR3 | 0.59283850 |
80 | MAP2K6 | 0.58739307 |
81 | MAPKAPK3 | 0.58095589 |
82 | PTK6 | 0.56756934 |
83 | STK4 | 0.55895855 |
84 | FLT3 | 0.55812925 |
85 | MAP3K6 | 0.53815334 |
86 | EGFR | 0.53116423 |
87 | ERBB3 | 0.51620427 |
88 | RPS6KL1 | 0.50718121 |
89 | RPS6KC1 | 0.50718121 |
90 | CAMKK2 | 0.50457803 |
91 | IRAK2 | 0.50445124 |
92 | MST1R | 0.50416586 |
93 | EPHA2 | 0.49271855 |
94 | ILK | 0.48507381 |
95 | MAP3K8 | 0.47638282 |
96 | RIPK1 | 0.47494762 |
97 | PRKG2 | 0.46622409 |
98 | DAPK3 | 0.45941457 |
99 | MAPKAPK2 | 0.45838152 |
100 | DAPK1 | 0.44848834 |
101 | LIMK1 | 0.43469383 |
102 | PDK1 | 0.42384877 |
103 | EPHB2 | 0.42039966 |
104 | EIF2AK3 | 0.40441085 |
105 | CLK1 | 0.39640589 |
106 | STK24 | 0.39136853 |
107 | EEF2K | 0.38657021 |
108 | CAMK1D | 0.37604110 |
109 | TNK2 | 0.37047726 |
110 | RPS6KA6 | 0.36563007 |
111 | EIF2AK2 | 0.36470338 |
112 | TAOK2 | 0.35959882 |
113 | MAP3K1 | 0.35016183 |
114 | MAPK4 | 0.34728755 |
115 | CDK6 | 0.34580858 |
116 | FYN | 0.34179768 |
117 | SIK1 | 0.34119399 |
118 | ARAF | 0.32674148 |
119 | MAP2K2 | 0.31781811 |
120 | PDGFRB | 0.31577765 |
121 | LMTK2 | 0.31315668 |
122 | MAP3K5 | 0.31014925 |
123 | ACVR1B | 0.30290330 |
124 | MAP3K10 | 0.29595501 |
125 | PAK1 | 0.29477909 |
126 | MAPK7 | 0.29139836 |
127 | PRKCQ | 0.28164166 |
128 | PIK3CG | 0.26576670 |
129 | IGF1R | 0.25341406 |
130 | EPHA3 | 0.25149991 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.27457063 |
2 | Lysosome_Homo sapiens_hsa04142 | 2.43072098 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.41835670 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.41781525 |
5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.39820985 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37408562 |
7 | Legionellosis_Homo sapiens_hsa05134 | 2.24949913 |
8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.19430752 |
9 | Malaria_Homo sapiens_hsa05144 | 2.14076927 |
10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.13243897 |
11 | Tuberculosis_Homo sapiens_hsa05152 | 2.09910794 |
12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.09568515 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08729637 |
14 | Pertussis_Homo sapiens_hsa05133 | 2.08132941 |
15 | Measles_Homo sapiens_hsa05162 | 2.02930268 |
16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99267659 |
17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99141522 |
18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.98757764 |
19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.90058367 |
20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.89425232 |
21 | Allograft rejection_Homo sapiens_hsa05330 | 1.88948475 |
22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.87404119 |
23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.85755676 |
24 | Asthma_Homo sapiens_hsa05310 | 1.84780922 |
25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84709055 |
26 | Phagosome_Homo sapiens_hsa04145 | 1.77943594 |
27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71601256 |
28 | Shigellosis_Homo sapiens_hsa05131 | 1.68034264 |
29 | Salmonella infection_Homo sapiens_hsa05132 | 1.66639557 |
30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66148179 |
31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56474054 |
32 | Apoptosis_Homo sapiens_hsa04210 | 1.54766950 |
33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49317329 |
34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47933528 |
35 | Influenza A_Homo sapiens_hsa05164 | 1.46781399 |
36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39265008 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38015367 |
38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.37815625 |
39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35162559 |
40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.29759770 |
41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.26878414 |
42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25539142 |
43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25159885 |
44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18468743 |
45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14853783 |
46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14117721 |
47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.11262106 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 1.09556288 |
49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00805011 |
50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91507866 |
51 | Bladder cancer_Homo sapiens_hsa05219 | 0.90606566 |
52 | Mineral absorption_Homo sapiens_hsa04978 | 0.90234112 |
53 | Prion diseases_Homo sapiens_hsa05020 | 0.88358442 |
54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87364294 |
55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86065896 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.84854477 |
57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84344366 |
58 | Amoebiasis_Homo sapiens_hsa05146 | 0.84232717 |
59 | Platelet activation_Homo sapiens_hsa04611 | 0.83972676 |
60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82215836 |
61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80116244 |
62 | Proteasome_Homo sapiens_hsa03050 | 0.79022589 |
63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78036377 |
64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77512930 |
65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76213231 |
66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76192875 |
67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74525469 |
68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70949471 |
69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69649251 |
70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68418866 |
71 | Ribosome_Homo sapiens_hsa03010 | 0.67789853 |
72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67588131 |
73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64974172 |
74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62727183 |
75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59707023 |
76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57151475 |
77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55495090 |
78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55353124 |
79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55141010 |
80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54551690 |
81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54526995 |
82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54293691 |
83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52760200 |
84 | Endocytosis_Homo sapiens_hsa04144 | 0.52103345 |
85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51881865 |
86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51261888 |
87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50885124 |
88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49611061 |
89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44179643 |
90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43795823 |
91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42722580 |
92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42450392 |
93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42145606 |
94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39531849 |
95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38779123 |
96 | Focal adhesion_Homo sapiens_hsa04510 | 0.37450600 |
97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33096184 |
98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32773395 |
99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31677405 |
100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30804293 |
101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30471809 |
102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29774875 |
103 | DNA replication_Homo sapiens_hsa03030 | 0.29445606 |
104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28556445 |
105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.26655192 |
106 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.26216729 |
107 | Base excision repair_Homo sapiens_hsa03410 | 0.25129428 |
108 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24460426 |
109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22918243 |
110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20690388 |
111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.13189791 |
112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.08914857 |
113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.06881783 |
114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.06448016 |